Market Size of Antacids Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 3.70 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Antacids Market Analysis
The Global Antacids Market size is expected to grow from USD 6,810.11 million in 2023 to USD 8,194.33 million by 2028, registering a CAGR of 3.7% during the forecast period (2023-2028).
The COVID-19 pandemic significantly impacted the market due to declining production and a labor shortage. The prices were higher than normal. However, because of the rising demand for new antacids and other medications, the market witnessed a favorable impact. This significantly increased the revenue of the market under study. Additionally, it was shown that various gastrointestinal medications successfully enhanced the clinical results of COVID-19 patients who were hospitalized. For instance, as per an article published in the View Open Access Journal in May 2022, acidosis-related pH promoted SARS-CoV-2 infection and suggested the existence of a positive feedback loop in which SARS-CoV-2 infection-induced acidosis enhances SARS-CoV-2 infection. Therefore, antacid therapy for acidosis COVID-19 patients was necessary during the pandemic. As per the above source, calcium carbonate nanoparticles (CaCO3-NPs) were an effective antacid nano antidote than sodium bicarbonate. Hence, the use of these medications increased during the pandemic and fueled the overall market growth. The studied market is anticipated to maintain its stronghold and grow significantly during the forecast period.
Factors such as the growing geriatric population suffering from gastroesophageal reflux disease (GERD), poor lifestyle choices leading to higher incidences of acidity, and side effects of drugs like non-steroidal, anti-inflammatory drugs are predicted to contribute to the market's growth over the analysis period.
As per a report released in May 2021 by HHS's Administration on Aging (AoA), the number of geriatric populations is expected to rise to 94.7 million by 2060. As per various sources, with the aging of the population, GERD is more common, with a prevalence of 20% or higher in the outpatient setting. Hence, the rising geriatric population is expected to rise, and the demand for antacids to treat GERD. Therefore, the market studied is anticipated to expand and grow during the forecast period.
Furthermore, according to a research report published in the Cureus journal in November 2021, the prevalence of GERD was 20.6% in the eastern region of Saudi Arabia. Numerous sociodemographic and lifestyle factors were linked to the illness. Therefore, rising prevalence would boost antacid demand and support market expansion over the projected period.
However, the growing number of alternatives available in the market to antacids and the ignorance of people towards the symptoms of acidity are expected to have an adverse impact on the market growth.
